Academy of Chiropractic Personal Injury & Primary Spine Care Program
Quickie Consult 67 CI
"MRI- Muscular Sclerosis (MS)”
MS is a very common and often challenging diagnosis, especially in the very early stages. Many believe that it is a conglomeration of diseases and not one singular entity. What is certain is that it is a demyelinating disease and if treated early, can be managed.
One hallmark is plaquing of the spinal cord and a finding we should be both experienced at detecting and looking for in every patient. We also must be aware that both radiculopathic and myelopathic findings have similar signs and symptoms.
Notice the higher density lesions.
Multiple sclerosis (MS) is a relatively common acquired chronic relapsing demyelinating disease involving the central nervous system. It is by definition disseminated not only in space (i.e multiple lesions), but also in time (i.e lesions are of different age).
A number of clinical variants are recognised, each with specific imaging findings and clinical presentation. They include:
· classic multiple scleroris (Charcot type)
· tumefactive multiple sclerosis
· acute malignant Marburg type
· Schilder type (diffuse cerebral sclerosis)
· Balo concentric sclerosis (BCS)
This articles concerns itself primarily with classic (Charcot type) multiple sclerosis. The other variants are discussed separately.
Of noteneuromyelitis optica(Devic disease) was considered a variant but is now recognised as a distinct entity.
Presentation is usually between adolescence and the sixth decade, with a peak at approximately 35 years of age12. There is a strong, well recognised female predilection with a F:M ratio of 2-3:1.
Multiple sclerosis has a fascinating geographic distribution: it is rarely found in equatorial regions, with incidence gradually increasing with distance from the equator12.
Clinical presentation is both highly variable acutely, as a result of varying plaque location as well as over time, with a number of patterns of longitudinal disease being described 11-12:
o most common (70% of cases)
o patients exhibit periodic symptoms with complete recovery (early on)
2. secondary progressive
o approximately 85% of patients with relapsing-remitting MS eventually enter a secondarily progressive phase
3. primary progressive
o uncommon (10% of cases)
o patients do not have remissions, with neurological deterioration being relentless
4. progressive with relapses
5. benign multiple sclerosis
o 15-50% of cases
o defined as patients who remain functionally active for over 15 years
As is evident from this list, there is overlap, and in some cases patients can drift from one pattern to another.
Upon presentation patients often have evidence of multiple previous asymptomatic lesions, and the diagnosis of multiple sclerosis can be strongly inferred. In other instances patients present with the first plaque. This is known as clinically isolated syndrome (CIS)and not all patients go on to develop MS.
Symptoms may be sensory or motor or mixed, including cranial nerve involvement e.g.trigeminal neuralgia or optic neuritis.
The exact aetiology is poorly known although it is believed to have both genetic and acquired contributary components. An infectious agent or at least catalyst have long been suspected due to the geographic distribution and presence of clusters of cases, however no agent has as yet been firmly identified.
MS is believed to result from a cellular mediated auto immune response against ones own myelin components, with loss of oligodendrocytes, with little or no axonal degeneration.
Demyelination occurs in discrete foci, termed plaques which range in size from a few millimetres to a few centimeters and are typically perivenular.
Each lesion goes through three pathological stages
· early acute stage(active plaques)
o active myelin break down
o plaques appear pink and swollen
· sub acute stage
o plaques become paler in colour ("chalky")
o abundant macrophages
· chronic stage(inactive plaques / gliosis)
o little or no myelin breakdown
o gliosis with associated volume loss
o appear grey / translucent
Patients serum IgG levels tend to be elevated and CSF analysis commonly shows oligoclonal bands
· a strong association with HLA-DR2 class II has been identified 11.
· Melkersson-Rosenthal syndrome: postulated
Plaques can occur anywhere in the central nervous system. They are typically ovoid in shape and perivenular in distribution.
CT features are usually non specific, and significant change may be seen on MRI with an essentially normal CT scan. Features that may be present include:
· plaques can be homogeneously hypo attenuating8, 11
· brain atrophy may be evident in with long standing chronic MS 5
· some plaques may show contrast enhancement in the active phase7, 11
MRI has revolutionised the diagnosis and surveillance of patients with MS. Not only can an MRI confirm the diagnosis (see McDonald MRI criteria for multiple sclerosis), but follow-up scans can assess response to treatment and try and determine the disease pattern.
o lesions are typically iso to hypo intense (chronic)
o callososeptal interface may have multiple small hypo intense lesions (Venus necklace) or the corpus callosum may merely appear thinned11
· T2 - lesions are typically hyper intense
o lesions are typically hyper intense
o when arranged perpendicular to lateral ventricles, extending radially outward (best seen on parasagittal images) they are termed Dawson fingers
· T1 C+ (Gd)-
o active lesions show enhancement
o enhancement is often incomplete around the periphery (open ring sign)
· DWI / ADC- active plaques may demonstrate restricted diffusion 10-11
· MR spectroscopy - may show reduced NAA peaks within plaques
Even on a single scan, some features are helpful in predicting relapsing-remitting vs progressive disease. Features favouring progressive disease include:
· large numerous plaques
· hypo intense T1 lesions
The differential diagnosis is dependent on the location and appearance of demyelination. For classic (Charcot type) MS the differential can be divided into intracranial and spinal involvement.
For intra cranial disease the differential includes almost all other demyelinating disease as well as:
· CNS fungal infection (e.g.Cryptococcus neoformans) - patients tend to be immunocompromised
· mucopolysaccharidoses (e.g. Hurler disease ) - congenital and occurs in a younger age group
· Marchiafava-bignami disease (for callosal lesions)
· Susac syndrome
· CNS manifestations of primary antiphospholipid syndrome13.
For spinal involvement the following should be considered:
· transverse myelitis
· spinal cord tumours - e.g astrocytomas
The differential for multiple sclerosis variants (e.gtumefactive MS,Devic disease etc.. see above) are discussed separately.